Zinger Key Points
- Auxly Cannabis' Q3 net revenue totaled CA$33.3 million ($24 million), compared to CA$28.2 million in the prior year’s period.
- Gross profit was CA$17.1 million in Q3, up from CA$4.6 million in the prior year’s quarter
- Benzinga shares with you top insiders news
Cannabis-focused consumer packaged goods company Auxly Cannabis Group Inc. XLY CBWTF released its financial results on Friday for the three and nine months ended Sept. 30, 2024.
“Our continued focus on efficient revenue growth and enhanced profitability has delivered another record-breaking quarter of financial results, highlighted by an 18% year-over-year increase in net revenue and record adjusted EBITDA of $8.3 million," said Hugo Alves, the company's CEO.
Q3 2024 Financial Highlights
- Net revenue totaled CA$33.3 million ($24 million), compared to CA$28.2 million in the prior year's period, representing an increase of 18%.
- Gross profit was CA$17.1 million, up from CA$4.6 million in the prior year's quarter.
- Total expenses amounted to CA$14.1 million, down from CA$19.1 million in the same period of last fiscal year.
- Net income amounted to CA$3.2 million, down from CA$31.6 million net income in the corresponding quarter of last year.
- Adjusted EBITDA came in positive at CA$8.3 million, up from an adjusted EBITDA gain of CA$117 000 in the same quarter of last year.
- Selling, general and administrative expenses were CA$8.5 million in the third quarter of 2024, CA$1.6 million or 16% lower than the same period in 2023.
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
Nine Months Ended Sept. 30, Financial Highlights
- Net revenue totaled CA$87.7 million, compared to CA$74.2 million in the prior year's period, representing an increase of 18%.
- Gross profit was CA$42.5 million, up from CA$18.5 million in the prior year's quarter.
- Total expenses amounted to CA$46.6 million, down from CA$54.5 million in the same period of last fiscal year.
- Net loss amounted to CA$20.8 million, compared to CA$9.5 million net income in the corresponding quarter of last year.
- Adjusted EBITDA came in positive at CA$15.7 million, up from an adjusted EBITDA loss of $CA823 000 in the same quarter of last year.
Outlook
Going forward, Auxly will prioritize focused and efficient growth in its key product categories of vape, pre-roll and dried flower and continue to optimize and improve distribution and sales of its products.
CBWTF Price Action
Auxly's shares traded 4.57% higher at $0.0366 per share at the time of writing on Friday.
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.